Researchers find that silent carriers of malaria are unlikely to develop the disease

June 8, 2018, University of Maryland School of Medicine
Credit: CDC

In regions where malaria illness is widespread, it is common to find many individuals who are infected with malaria parasites (Plasmodium falciparum), but without symptoms. New research conducted by the University of Maryland School of Medicine (UMSOM) shows that treating these silent malaria cases could help stop the spread of malaria to others.

UMSOM researchers conducted a study of 114 participants in Malawi ranging from children to adults to better understand the role asymptomatic infections have in the spread and occurrence of malaria illness. It is the first study to use prospective, longitudinal detection of asymptomatic malaria infection to examine subsequent risk of malaria illness among all ages.

These asymptomatic infections may never develop into illness, but they are an important contributor to the spread of malaria and pose a public health challenge.

"We know that in Malawi, like many parts of Africa, most of the malaria parasites are being carried by people who are not sick. They don't get treatment for their infections, because their infections a silent, but when they get bitten by mosquitoes, they can transmit malaria" said Miriam Laufer, MD, MPH, Associate Professor of Pediatrics and Associate Director for Malaria Research in UMSOM's Center for Vaccine Development and Global Health (CVD).

Researchers examined the association between asymptomatic malaria infections and subsequent risk of malaria illness and demonstrated that carrying P. falciparum infection without symptoms was associated with a 50% decrease in the risk of malaria illness.

Using a genotyping method to determine the molecular fingerprint of each parasite, they discovered when people who have asymptomatic malaria infection and get sick from malaria, it is because they acquire a new infection (from the bite of a mosquito) rather than having the asymptomatic infection develop into clinical disease. With new infections, adults and children with and without asymptomatic infection were equally likely to get sick. The researchers concluded that asymptomatic infection did not protect against new infections that made them sick.

"We have always worried that if we give medicine to treat malaria to people with asymptomatic infection, they might get sicker the next time they get malaria. This has been a challenge to introducing new policies like mass drug administration or screening and treating campaigns to interrupt malaria transmission. Our results suggest that treating asymptomatic will not lead to increased risk of disease in the short term. Now we need to evaluate these new interventions to determine the long term impact both on the individual's health and also on " said Dr. Laufer.

Researchers enrolled participants seeking treatment for uncomplicated malaria at the Mfera Health Centre in Chikhwawa district in Malawi between June 2014 and March 2015. Subjects were eligible if they had symptomatic P. falciparum infection, detected by malaria rapid diagnostic test (RDT) and confirmed by microscopy, and were HIV-negative at time of screening. They were treated for their initial and then followed every month and evaluated every time they were ill.

Explore further: Altered body odor indicates malaria even if microscope doesn't

Related Stories

Altered body odor indicates malaria even if microscope doesn't

May 14, 2018
Typhoid Mary may have infected a hundred or more people, but asymptomatic carriers of malaria infect far more people every year. An international team of researchers is working toward a way to identify malaria patients including ...

Researchers describe the dynamics of P. falciparum infections in adults without fever

March 30, 2018
Asymptomatic malaria occurs when parasites are present in an individual's blood, but do not cause fever or other symptoms. These "afebrile" infections can be detected either by classical diagnostic tests (if there are enough ...

Human antibodies undermine parasite sex

February 8, 2018
Some people develop an immune response following a malaria infection that stops them from infecting other mosquitoes. The antibodies that these people produce are ingested by the mosquito and destroy the malaria parasite ...

Newly described human antibody prevents malaria in mice

March 19, 2018
Scientists have discovered a human antibody that protected mice from infection with the deadliest malaria parasite, Plasmodium falciparum. The research findings provide the basis for future testing in humans to determine ...

Discovery of key molecules involved in severe malaria – new target for malaria vaccine

December 4, 2017
Malaria is one of three major infectious diseases affecting approximately 300 million people every year, accounting for about 500,000 deaths, but effective vaccine development has not been successful. Among malaria parasites ...

Mini-primaquine does help stop people infecting mosquitoes with malaria

February 2, 2018
A single dose of primaquine is thought to stop people with P. falciparum malaria infecting mosquitoes, which could help bring down malaria transmission. In this Cochrane Review update prepared by an international team of ...

Recommended for you

Taking the virus out of a mosquito's bite

December 12, 2018
They approach with the telltale sign—a high-pitched whine. It's a warning that you are a mosquito's next meal. But that mosquito might carry a virus, and now the virus is in you. Now, with the help of state-of-the-art technology, ...

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

Human antibody discovery could save lives from fungal killer

December 11, 2018
A new way to diagnose, treat and protect against stealth fungal infections that claim more than 1.5 million lives per year worldwide has been moved a step closer, according to research published in Nature Communications.

Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism

December 11, 2018
Treatment with active vitamin D did not decrease cardiovascular events in kidney patients undergoing hemodialysis, according to a research group in Japan. They have reported their research results in the December 11 issue ...

Dialysis patients at risk of progressive brain injury

December 10, 2018
Kidney dialysis can cause short-term 'cerebral stunning' and may be associated with progressive brain injury in those who receive the treatment for many years. For many patients with kidney failure awaiting a kidney transplant ...

PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds

December 6, 2018
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain—or tuberculosis meningitis (TBM)—is often deadly, always hard to treat, and a particular ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.